# Apollomics, Inc.

**Canonical:** https://apis.io/providers/apollomicsinc/  
**Website:** https://apollomicsinc.com  
**APIs profiled:** 0

Apollomics, Inc. (Nasdaq: APLM) is a clinical-stage biopharmaceutical company headquartered in Foster City, California, focused on the discovery and development of oncology therapies designed to be combined with other treatments to harness the immune system and target specific molecular pathways that inhibit cancer. Operating since 2016, Apollomics has a pipeline of nine drug candidates spanning small-molecule targeted drugs and biologics, including late-stage programs such as vebreltinib (Phase 2, NSCLC and solid tumors with cMet dysregulation) and uproleselan (Phase 3 in China for relapsed/refractory AML). The company became publicly traded via a business combination with Maxpro Capital Acquisition Corp. Surfaced as a portfolio company of Qiming and added to the API Evangelist network; as a biopharmaceutical company it publishes no public developer API surface — this profile carries its corporate identity and domain-security posture.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Apollomicsinc Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biopharmaceutical, Oncology, Precision Medicine, Clinical Trials, Drug Development, Healthcare, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/apollomicsinc/). Scores are computed from the provider's own public artifacts under a published rubric.